Sumitomo Mitsui Trust Group
NVO

Sumitomo Mitsui Trust Group’s Novo Nordisk NVO Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,339
Closed -$619K – 1091
2024
Q2 		$619K Sell
4,339
-4,887
-53% -$648K ﹤0.01% 946
2024
Q1 		$1.18M Sell
9,226
-2,325
-20% -$277K ﹤0.01% 954
2023
Q4 		$1.19M Buy
11,551
+315
+3% +$31.2K ﹤0.01% 959
2023
Q3 		$1.02M Buy
11,236
+4,414
+65% +$389K ﹤0.01% 983
2023
Q2 		$552K Buy
+6,822
New +$557K ﹤0.01% 1051

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sumitomo Mitsui Trust Group's NVO Position: Q3 2024 in Review

Sumitomo Mitsui Trust Group sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 4,339 shares — an estimated $619K sold.

Sumitomo Mitsui Trust Group first reported a position in NVO in Q2 2023 and held it in 5 quarters. The position peaked at $1.19M in Q4 2023. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Sumitomo Mitsui Trust Group reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 4,339 Novo Nordisk shares in Q3 2024, an estimated $619K.
  • Sumitomo Mitsui Trust Group first reported a position in Novo Nordisk in Q2 2023 and held it in 5 quarters.
  • Sumitomo Mitsui Trust Group's Novo Nordisk position peaked at $1.19M in Q4 2023.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2024, filed 5 Nov 2024.